Login / Signup

[Experience of using a Russian alteplase product as thrombolytic therapy in patients with ischemic stroke in routine practice].

D M MurtazalievaA R ZakaryaevaT D SoshinaM A ZolotovV A Parfenov
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
Revelisa has demonstrated high efficacy and safety when used for TLT in patients with IS in real-world clinical practice.
Keyphrases
  • clinical practice
  • acute ischemic stroke
  • pulmonary embolism
  • primary care
  • healthcare
  • atrial fibrillation
  • quality improvement
  • stem cells
  • cell therapy
  • smoking cessation
  • replacement therapy